Ocutrx Technologies, Inc. ("Ocutrx"), a leader in augmented reality (AR) and 3D technology for medical, enterprise, and ...

PepsiCo faces persistent headwinds, including financially constrained consumers, product recalls, and higher CapEx. Read why ...

Fischer notes that the Celtics spent some time this month gauging the value of reserve guard Jaden Springer before final ...

Edible oil and flour maker Adani Wilmar could raise prices of cooking oil by at least 20% in the current quarter following ...

There are no optometrists or ophthalmologists in many parts of the US. Eyebot aims to make it easier to get your vision ...

Oklo shares soared to a new record high Monday as investors continue piling into the Sam Altman-backed Nuclear energy startup ...

Good Vision Liberia (GVL), which provides optical services globally, organized a four-day eye screening and blindness prevention for primary school students and teachers. In an exclusive interview ...

Buy EYE near 8.35 target 11.61 stop loss @ 8.33 Details The technical summary data tells us to buy EYE near 8.35 with an upside target of 11.61. This data also tells us to set a stop loss @ 8.33 to ...

Retinal vein occlusions are similar to retinal artery occlusion (RAO), sometimes called an eye stroke, but are more common. In fact, it’s the second most common condition that affects the retina.

The Biden-Harris administration has pushed for a cease-fire, but the White House's relationship with Israeli Prime Minister Benjamin Netanyahu has been tested as he charts his own course ...

underperforming the Basic Materials sector's gain of 8.15% and outperforming the S&P 500's gain of 4.3%. Analysts and investors alike will be keeping a close eye on the performance of Newmont ...